
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















Integration of Artificial Intelligence in Predicting Radiotherapy Outcomes for Glioblastoma Multiforme (GBM)
Author(s) | Dr. Sayed Ali Sajad Tabibi, Dr. Luqmaan Abdullahi Ali, Dr. Hampi Jyothi, Dr. Emad Asasfeh, Dr. Warda Berair Mustafa Abdelgani |
---|---|
Country | India |
Abstract | Glioblastoma multiforme (GBM) is an aggressive and lethal brain tumor with limited treatment options and a poor prognosis. Radiotherapy is a cornerstone of GBM management, yet predicting treatment response remains a challenge due to tumor heterogeneity. Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), has emerged as a promising tool for enhancing predictive accuracy and personalizing treatment strategies. This systematic review evaluates the current advancements in AI-driven models for predicting radiotherapy outcomes in GBM patients. A comprehensive search of PubMed, Scopus, and Web of Science identified 35 relevant studies employing various AI methodologies, including ML, DL, and hybrid approaches. The results indicate that convolutional neural networks (CNNs) and hybrid AI models incorporating radiomics and genetic biomarkers achieved the highest predictive performance, with accuracy rates ranging from 75% to 92% and area under the curve (AUC) values up to 0.91. Despite these advancements, challenges such as data heterogeneity, small sample sizes, and model interpretability remain significant barriers to clinical implementation. Future research should focus on large-scale multicenter collaborations, the integration of multi-omics data, and the development of explainable AI (XAI) models to enhance transparency and clinical applicability. This systematic review aims to: 1. Comprehensively evaluate the performance characteristics of various AI models in predicting key radiotherapy outcomes for GBM, including overall survival (OS), progression-free survival (PFS), patterns of failure, and treatment-related toxicities such as radiation necrosis 2. Assess the incremental value of integrating multiple data modalities (e.g., structural and functional imaging, molecular biomarkers, dosimetry) in predictive model performance 3. Critically examine methodological considerations in AI model development and validation specific to GBM radiotherapy applications 4. Identify current barriers to clinical implementation and propose pathways for translation of these technologies into routine neuro-oncology practice |
Keywords | Glioblastoma multiforme, Artificial intelligence, Machine learning, Deep learning, Radiotherapy outcomes, Predictive modeling, Radiomics, Explainable AI, Personalized treatment. |
Field | Biology |
Published In | Volume 7, Issue 4, July-August 2025 |
Published On | 2025-07-20 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.51688 |
Short DOI | https://doi.org/g9t2dw |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
